2024-11-04 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis

### 1. Performance vs. S&P 500 (VOO)

**UnitedHealth Group Inc. (UNH)** is a leading healthcare company providing health insurance, managed care, and other healthcare services.

**Cumulative Return:**
* **UNH:** 286.33%
* **VOO:** 131.78%

**Outperformance:**
* **Current Outperformance:** 154.55%
* **Relative Outperformance:** 62.68% (meaning UNH has outperformed VOO by 62.68% relative to its historical range of outperformance)

**Alpha and Beta Analysis:**
* **UNH has generally outperformed the market (VOO) over the past 10 years.** This is evidenced by its consistently positive alpha values, which are especially notable in 2016, 2017, and 2021.
* **UNH's beta has fluctuated over the years, indicating varying sensitivity to the broader market.** However, it has generally been higher than 1, suggesting that UNH tends to move more than the market.

### 2. Recent Price Movements

* **Closing Price:** $567.56
* **5-Day Moving Average:** $564.48
* **20-Day Moving Average:** $573.73
* **60-Day Moving Average:** $580.70

**Current price is slightly below its recent moving averages, suggesting potential for a short-term rebound.**

### 3. Technical Indicators

* **RSI:** 30.8 (suggests the stock is currently in oversold territory)
* **PPO:** -0.11 (suggests a potential for a trend reversal)
* **Delta_Previous_Relative_Divergence:** -6.53 (indicates short-term downward pressure)
* **Expected Return:** 53.42% (projected long-term outperformance compared to S&P 500)

**Overall, technical indicators suggest short-term weakness but potential for long-term upside, especially given the strong expected return.**

### 4. Recent Earnings and Outlook

**Recent Earnings:**

| Date       | EPS      | Revenue       |
|------------|----------|---------------|
| 2024-08-09 | $4.58    | $98.86B      |
| 2024-05-09 | -$1.53   | $99.80B      |
| 2023-11-06 | $6.31    | $92.36B      |
| 2023-08-02 | $5.89    | $92.90B      |
| 2024-08-09 | $5.89    | $92.90B      |

* **Latest earnings exceeded expectations and showed continued revenue growth, demonstrating strong performance despite recent market volatility.**

### 5. Financial Information

**1) Revenue and Profitability:**

| Quarter      | Revenue      | Profit Margin |
|--------------|--------------|---------------|
| 2024-06-30  | $97.86B     | 21.52%       |
| 2024-03-31  | $98.78B     | 22.26%       |
| 2023-12-31  | $93.25B     | 22.33%       |
| 2023-09-30  | $91.36B     | 24.51%       |
| 2023-06-30  | $91.79B     | 23.72%       |

* **Steady revenue growth with consistent profitability.**

**2) Capital and Profitability:**

| Quarter      | Equity      | ROE       |
|--------------|--------------|-----------|
| 2024-06-30  | $89.36B     | 4.72%    |
| 2024-03-31  | $86.69B     | -1.63%   |
| 2023-12-31  | $88.76B     | 6.15%    |
| 2023-09-30  | $84.49B     | 6.91%    |
| 2023-06-30  | $82.35B     | 6.65%    |

* **Strong equity position and generally high ROE.**

### 6. News and Recent Issues

* **To provide an accurate analysis, please provide the date of the latest earnings report and any specific news articles or reports.**
* **I can analyze these to provide insights on recent market outlook, analyst opinions, and performance highlights.**

### 7.  Comprehensive Analysis

**UNH remains a strong performer in the healthcare sector with consistent revenue growth, profitability, and a solid financial foundation.**  Despite some short-term weakness, the stock's strong long-term expected return and oversold technical indicators make it a potentially attractive investment for those with a long-term horizon. 

**However, it's crucial to consider recent news and market conditions, as well as your individual investment goals and risk tolerance before making any investment decisions.** 
